Population pharmacokinetic modelling of roflumilast and roflumilast N-oxide by total phosphodiesterase-4 inhibitory activity and development of a population pharmacodynamic-adverse event model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples